Basic information |
Metabolite name | LysoPC(O-18:0) |
N/A | |
C04230 | |
N/A | |
Synonyms | NA |
No. of studies | 6 |
Relationship between LysoPC(O-18:0) and depression (count: 6) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
Study M1117 | Type1 | MDD group vs. control group, Russian cohort | Plasma | Human | Down |
Study M210 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
Study M210 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
Study M210 | Type2 | CUMS + curcumin group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
Study M768 | Type1 | depression group vs. control group | Serum | Human | Down |
Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
Study M972 | Type1 | CRS + irradiation group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M972 | Type2 | CRS + irradiation + albiflorin group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |
Study M972 | Type2 | CRS + irradiation + Paeoniae Radix Alba group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |